Tetra Tech Q2 results show 8% ex-USAID growth, but risks linger

What happened

Tetra Tech's fiscal Q2 2026 net revenue rose 8% year-over-year excluding USAID/DOS and disaster work, totaling $1.05B, while operating income reached $132M, beating guidance. This marks the second consecutive quarter of improvement after the USAID loss, with management raising full-year guidance. The DeepValue Master Report's base case assumes 4–6% net revenue growth, so the 8% ex-USAID performance is a positive data point that supports the replacement thesis. However, the report also highlighted thin margin of safety due to legal tail risk (e.g., $115M Hunters Point contingency) and reliance on episodic disaster work, which the Q2 release did not address. The raised guidance is encouraging, but one quarter does not confirm a sustainable trend, and the stock still trades at ~29x trailing P/E, leaving limited cushion for setbacks.

Implication

The Q2 beat and guidance raise support the narrative that Tetra Tech is successfully backfilling the USAID revenue hole with higher-margin government and defense work. However, the DeepValue Report's WAIT rating reflects a thin valuation buffer and event-driven risk. Investors should view this as incremental progress, not a all-clear. The thesis delta is modestly positive: the probability of the base case (4–6% growth) has increased, but the bull case (7–9%) requires sustained execution and margin expansion. The attractive entry point of $34 remains a better risk-reward; current price near $39 still offers limited upside. Monitor Q3 results for further confirmation and any update on the legal settlement.

Thesis delta

The thesis shifts modestly positive: the Q2 results and raised guidance increase confidence that ex-USAID net revenue growth can achieve the 4–6% base case, possibly trending toward the upper end. However, the bear-case risks (legal charges, policy cuts) remain salient, and the stock's valuation still provides little buffer. The probability of the base case moves from 50% to ~55%, with bull case risk unchanged at 25%. The watch-and-wait stance should continue until more quarters confirm the trend and legal overhang clears.